Browse all articles

Home Get the app

Head to head Published Apr 18, 2026

Trans-Resveratrol vs Pterostilbene for Longevity Buyers

Pick Trans-Resveratrol if you want the better-studied longevity molecule with more randomized trial and safety evidence. Pick Pterostilbene if your priority is absorption and lower-pill, lower-milligram dosing, but check LDL cholesterol because the human evidence is smaller and lipid signals are less reassuring.

Evidence: promising 9 criteria 8 sources

Evidence summary

Evidence summary

For health-conscious supplement buyers prioritizing daily longevity evidence, trans-resveratrol is the better-backed choice; for absorption and lower-milligram dosing, pterostilbene wins.

  • Trans-resveratrol has the deeper human evidence base, with randomized-trial meta-analyses showing small cardiometabolic shifts, not longevity-sized gains. 2
  • Pterostilbene reaches higher oral exposure than resveratrol, so lower milligram doses can deliver comparable bloodstream levels. 6
  • Pterostilbene raised LDL cholesterol in one placebo-controlled trial, so lipid-sensitive buyers need caution. 5

The verdict

Trans-Resveratrol is the more evidence-backed default for health-conscious longevity buyers because it has multiple randomized trial meta-analyses, an umbrella review, and clearer regulatory safety context.124 Pterostilbene is the more absorption-oriented choice and may be appealing for buyers who dislike high-dose resveratrol, but its human evidence is still preliminary and the possible LDL cholesterol signal makes it a less universal pick.568

The contenders

Two ways to approach the same goal

Option A

Trans-Resveratrol

Standardization

Usually sold as trans-resveratrol, the more biologically relevant isomer. Labels commonly state a percentage purity such as 98 percent trans-resveratrol, often from Japanese knotweed root or synthetic material. Supplement labels vary widely, and one academic review notes capsules can range from less than 1 mg to 500 mg per tablet or capsule.

Forms

Capsules, tablets, powders, liposomal liquids, and combination products with nicotinamide riboside, quercetin, piperine, or other polyphenols.

Typical dosage

Common human trials use about 75 mg to 1,500 mg daily depending on outcome and population. The European Food Safety Authority evaluated synthetic trans-resveratrol as a novel food supplement at up to 150 mg per day for adults, while many metabolic trials use several hundred milligrams daily.

Strengths

  • Best human evidence base of the two. A 2026 umbrella review included 45 systematic reviews of randomized trials and found high-certainty evidence for small improvements in waist circumference, total cholesterol in overweight adults, and blood pressure in people with type 2 diabetes.
  • May support cardiometabolic markers, especially in people with existing metabolic risk. A meta-analysis of randomized trials reported reductions in fasting glucose, total cholesterol, and C-reactive protein, a blood marker linked with inflammation.
  • More regulatory and safety context than pterostilbene. The European Food Safety Authority assessed synthetic trans-resveratrol for adult supplement use up to 150 mg per day.

Trade-offs

  • Poor exposure to unchanged resveratrol after oral dosing. Human pharmacokinetic work found high absorption but very low bioavailability of unchanged resveratrol because the body rapidly converts it into metabolites.
  • No strong human evidence that it extends lifespan. The better-supported claims are modest changes in measurable markers such as blood pressure, cholesterol, waist circumference, glucose, and inflammation markers.
  • Higher-dose supplements may be more interaction-prone because resveratrol can affect platelet function and drug-metabolizing enzymes in laboratory and human studies.

Safety

Use caution with anticoagulant drugs, antiplatelet drugs, nonsteroidal anti-inflammatory drugs, and medications processed by cytochrome P450 enzymes, which are liver and gut enzymes that help clear many drugs. Linus Pauling Institute also advises avoiding resveratrol supplements in people with a history of estrogen-sensitive cancers until more is known.3

Option B

Pterostilbene

Standardization

Usually sold as pterostilbene, often at high stated purity such as 99 percent. It is a methylated analog of resveratrol, meaning two chemical groups make it more fat-soluble and slower to be modified by the body.

Forms

Capsules and tablets, often as a standalone 50 mg to 100 mg ingredient or in longevity blends with nicotinamide riboside, nicotinamide mononucleotide, resveratrol, quercetin, or fisetin.

Typical dosage

Human trials have commonly tested 50 mg twice daily, 125 mg twice daily, or 250 mg per day for 6 to 8 weeks. One randomized, double-blind, placebo-controlled study tested doses up to 250 mg per day in adults with elevated cholesterol.

Strengths

  • Better pharmacokinetic profile than resveratrol in indirect evidence. Comparative animal pharmacokinetic work found higher oral bioavailability and higher total plasma levels for pterostilbene than resveratrol after oral dosing.
  • A randomized, double-blind, placebo-controlled trial in adults with elevated cholesterol found high-dose pterostilbene lowered systolic blood pressure by 7.8 mmHg and diastolic blood pressure by 7.3 mmHg, although lipid changes were mixed.
  • Short-term human safety data are reassuring up to 250 mg per day for 6 to 8 weeks in the main dose-ranging trial, but the evidence base is much smaller than for resveratrol.

Trade-offs

  • Much thinner human outcomes evidence than resveratrol. The key human pterostilbene trial was short and focused on cardiometabolic markers, not long-term aging outcomes.
  • May raise low-density lipoprotein cholesterol, commonly called LDL cholesterol, in some users. In the main clinical trial, lipid findings were unfavorable in some groups, and the authors noted baseline cholesterol medication affected lipid responses.
  • Usually costs more per capsule and per studied milligram than generic trans-resveratrol because fewer commodity suppliers and finished products compete on price. This is a market observation rather than a clinical efficacy finding.

Safety

Pterostilbene has short-term human safety data up to 250 mg per day, but long-term safety, pregnancy safety, and medication interaction data are limited. People monitoring LDL cholesterol should recheck lipids after starting it because the main trial raised concern about lipid effects in some users.58

Head-to-head

How they compare, criterion by criterion

Human efficacy evidence for buyer-relevant outcomes

Winner: A · Trans-Resveratrol

Importance: high

Trans-resveratrol wins because a 2026 umbrella review summarized 45 systematic reviews of randomized trials and found high-certainty evidence for modest improvements in waist circumference, total cholesterol in overweight adults, and blood pressure in type 2 diabetes.1 Pterostilbene has one key short-term randomized trial in adults with elevated cholesterol, which is useful but far narrower.5

Longevity-specific proof

Winner: Tie · Either option

Importance: high

Neither molecule has strong human evidence showing longer lifespan or slower biological aging in healthy adults. Current human evidence mainly measures intermediate markers such as blood pressure, lipids, glucose, waist circumference, and inflammation markers rather than lifespan or validated aging outcomes.15

Bioavailability and formulation efficiency

Winner: B · Pterostilbene

Importance: high

Pterostilbene wins on absorption logic and pharmacokinetics. Comparative oral dosing in rats found pterostilbene produced greater bioavailability and higher total plasma levels than resveratrol, while human resveratrol work shows high absorption but very low unchanged resveratrol after the body rapidly converts it into other forms.67 In plain terms, pterostilbene is more likely to stay in its original form after swallowing.

Cardiometabolic marker support

Winner: A · Trans-Resveratrol

Importance: high

Trans-resveratrol wins overall because its effects have been tested across many randomized trials and meta-analyses. Reported benefits include small improvements in fasting glucose, total cholesterol, C-reactive protein, waist circumference, and blood pressure in selected populations.12 Pterostilbene showed blood pressure reductions in one trial, but lipid results were mixed and potentially unfavorable for LDL cholesterol.5

Safety and interaction clarity

Winner: A · Trans-Resveratrol

Importance: high

Trans-resveratrol wins for clarity, not because it is interaction-free. It has more published safety discussion, including European Food Safety Authority review for 150 mg per day adult supplement use and detailed interaction cautions from Linus Pauling Institute.34 Pterostilbene has reassuring short-term data up to 250 mg per day, but fewer long-term and drug-interaction data.8

Tolerability at typical doses

Winner: Tie · Either option

Importance: medium

Both appear generally tolerable in short-term human use. Resveratrol has a broader safety literature but more interaction cautions at high supplemental intakes, while pterostilbene was tolerated up to 250 mg per day for 6 to 8 weeks in the main dose-ranging trial.38

Standardization and quality control

Winner: A · Trans-Resveratrol

Importance: medium

Trans-resveratrol wins slightly because it has a mature supplement market, common high-purity trans-isomer labeling, and regulatory discussion of synthetic trans-resveratrol.34 Pterostilbene can also be standardized, but there is less clinical and regulatory scaffolding for buyers to judge label claims.

Cost and value per evidence-backed dose

Winner: A · Trans-Resveratrol

Importance: medium

Trans-resveratrol wins for value because generic 98 percent trans-resveratrol is widely available and supported by a larger body of human trial evidence.13 Pterostilbene often requires fewer milligrams, but the evidence-backed use case is narrower, so the buyer is paying more for pharmacokinetic promise than for proven human outcomes.

Best fit for minimalist supplement stacks

Winner: B · Pterostilbene

Importance: low

Pterostilbene wins if the buyer wants a small-dose stilbene in a low-capsule longevity stack. Human trials commonly used 50 mg twice daily or 125 mg twice daily, while many resveratrol trials use several hundred milligrams daily.58 The trade-off is less human efficacy evidence and a need to monitor LDL cholesterol.

Which should you choose

By goal and use case

You want the most evidence-backed daily longevity molecule

Choose A · Trans-Resveratrol

Choose Trans-Resveratrol. It has the broader human evidence base, including an umbrella review of randomized trial meta-analyses, while pterostilbene has far fewer human trials.15

You care most about absorption and lower milligram dosing

Choose B · Pterostilbene

Choose Pterostilbene. Its chemical structure makes it more fat-soluble, and comparative pharmacokinetic evidence shows higher oral bioavailability than resveratrol in animal testing.6 This does not prove better longevity outcomes, but it does support the lower-dose positioning.

You have elevated LDL cholesterol or are closely managing lipids

Choose A · Trans-Resveratrol

Choose Trans-Resveratrol, or ask a clinician before using pterostilbene. Pterostilbene lowered blood pressure in one trial but had mixed lipid effects, with concern around LDL cholesterol in some groups.5

You take blood thinners, antiplatelet drugs, frequent anti-inflammatory pain relievers, or many prescription medications

Choose Tie · Either option

Choose neither without clinician review. Resveratrol has clearer cautions for platelet effects and drug-metabolizing enzymes, while pterostilbene has less interaction research, which means uncertainty rather than proven safety.38

You want a budget-friendly polyphenol with flexible dosing options

Choose A · Trans-Resveratrol

Choose Trans-Resveratrol. It is widely sold in many strengths, often from Japanese knotweed or synthetic sources, and its evidence base is stronger for the price category.13

You already tried resveratrol and stopped because capsules were too many or too large

Choose B · Pterostilbene

Pterostilbene is reasonable to consider if you accept the smaller human evidence base. It is commonly studied at 50 mg twice daily to 125 mg twice daily, which is a smaller milligram load than many resveratrol protocols.58

Safety considerations

Do not treat either compound as proven life-extension therapy. For Trans-Resveratrol, the most practical cautions are bleeding risk with anticoagulant or antiplatelet drugs, possible interaction with common drug-clearing enzymes, and avoidance in people with a history of estrogen-sensitive cancers unless a clinician advises otherwise.3 For Pterostilbene, the main practical cautions are limited long-term human safety data, limited medication interaction data, and the need to monitor LDL cholesterol if you use it regularly.58 Pregnant or breastfeeding people, people preparing for surgery, and people taking multiple prescription medicines should avoid self-experimentation with either compound unless their clinician reviews the full supplement stack.

Frequently asked

Common questions

Can I take trans-resveratrol and pterostilbene together?

You can find products that combine them, but there is no strong human evidence that stacking both improves longevity outcomes. Combining them also makes it harder to know which ingredient is affecting blood pressure, digestion, bruising, or cholesterol.

Should these be taken with food?

Taking either with a meal is a practical choice for tolerance. Pterostilbene is more fat-soluble, so taking it with a meal that contains some fat is reasonable, although this is based more on chemistry and absorption logic than on large human outcome trials.

Is pterostilbene just a stronger resveratrol?

No. Pterostilbene is more absorption-friendly, but stronger absorption does not automatically mean better health outcomes. Resveratrol currently has the stronger human trial base, while pterostilbene has the stronger pharmacokinetic story.

What lab markers should I monitor if using these long term?

For pterostilbene, LDL cholesterol is the most practical marker to recheck. For either compound, people with metabolic goals may track blood pressure, fasting glucose, hemoglobin A1c, and lipids with their clinician.

Which one is better for healthy adults without metabolic issues?

Neither has strong proof of meaningful benefit in already healthy adults. If you still want to choose one, trans-resveratrol is the more evidence-backed default, while pterostilbene is the absorption-focused experiment.

Related

Read each variant on its own

Standalone evidence guides and systematic reviews for the supplements being compared here.

Sources

  1. 1. Effects of resveratrol supplementation on multiple health outcomes: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials (2026) Umbrella review of randomized trial meta-analyses ↑
  2. 2. Effects of resveratrol supplementation on risk factors of non-communicable diseases: A meta-analysis of randomized controlled trials (2017) Meta-analysis of randomized controlled trials ↑
  3. 3. Resveratrol (2024) Academic micronutrient monograph ↑
  4. 4. Safety of synthetic trans-resveratrol as a novel food pursuant to Regulation (EC) No 258/97 (2016) Regulatory safety opinion ↑
  5. 5. Pterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial (2014) Randomized, double-blind, placebo-controlled clinical trial ↑
  6. 6. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats (2011) Comparative pharmacokinetic study ↑
  7. 7. High absorption but very low bioavailability of oral resveratrol in humans (2004) Human pharmacokinetic study ↑
  8. 8. Analysis of Safety from a Human Clinical Trial with Pterostilbene (2013) Human clinical safety analysis ↑

Want personalized recommendations?

Show me what works for me